Clinical Trial Update: A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating azithromycin sustained-release for laryngopharyngitis, tonsillitis, or acute bacterial rhinosinusitis has completed. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Rhinosinusitis
• Laryngopharyngitis
• Tonsillitis

Drugs mentioned

• Azithromycin SR (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Upper Respiratory Tract Infection | Phase 3 | Status: COMPLETED